alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
HomeOffice of the SpokespersonPress Releases...On the Passing of Sir Anerood Jugnauth

# 									On the Passing of Sir Anerood Jugnauth							

Press Statement

Ned Price, Department Spokesperson

June 6, 2021

We offer our sincere condolences to the people and Government of Mauritius on the passing of former Prime Minster and President Sir Anerood Jugnauth.

Sir Anerood Jugnauth had a long history of service to his country. Throughout his nearly 60 years at the forefront of Mauritian politics, he advocated for the ideals of democracy and a free market economy.  Together, we share his vision of a bright future for Mauritius through economic opportunity and sustainable development.

We mourn with the Jugnauth family and with the Mauritian government and people.  We stand with all Mauritians as they honor the memory of Sir Anerood Jugnauth.

 

Tags

Bureau of African AffairsMauritiusOffice of the Spokesperson

## Related Articles

-  											 									
Read more
 

Back to Top
Appeal Dismissed and Memor andum Opinion filed November 8 , 2018

.

In The 

## Fourteenth Court of Appeals

NO. 14- 18 -00885- CR

BRYCE GRANT, Appellant

V.
THE STATE OF TEXAS, Appellee

On Appeal from the 230th District Court

Harris County, Texas Trial Court Cause No. 1556234

M E M O R A N D U M O P I N I O N Appellant entered a plea of guilty to theft. Appellant and the State agreed that appellant’s punishment would not exceed confinement in prison for more than 180 days. In accordance with the terms of this plea bargain agreement with the State, the trial court sentenced appellant to confinement for 180 days in the Institutional Division of the Texas Department of Criminal Justice.2

The trial court entered a certification of the defendant’s right to appeal in which the court certified that this is a plea bargain case, and the defendant has no right of appeal. See Tex. R. App. P. 25.2(a)(2). The trial court’s certification is included in the record on appeal. See Tex. R. App. P. 25.2(d). The record supports
the trial court’s certification. See Dears v. State , 154 S.W.3d 610, 615 (Tex. Crim. App. 2005). Accordingly, we dismiss this appeal.

PER CURIAM Panel consists of Justices Boyce, Christopher, Jewell. Do Not Publish – Tex. R. App. P. 47.2(b)
HomeNATO Status Lists...29. Protocol to the North Atlantic Treaty on the Accession of the Republic of Latvia, done at Brussels March 26, 2003

# 									29. Protocol to the North Atlantic Treaty on the Accession of the Republic of Latvia, done at Brussels March 26, 2003							

Depositary – Treaty Affairs

Office of Treaty Affairs

Entered into force February 27, 2004.

Enters into force when each of the parties to the North Atlantic Treaty has notified the Government of the United States of America of its acceptance of the Protocol.
Download Status List						 [34 KB]

Tags

MultilateralNorth Atlantic Treaty OrganizationTreaties

Back to Top
Exhibit 99.1

			CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
					AS ADOPTED PURSUANT TO
			SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned have executed this certification in connection with the filing
with the Securities and Exchange Commission of the Companys Quarterly Report
on Form 10-QSB for the period ending March 31, 2003. The undersigned hereby
certifies that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and

(2) information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.



March 31, 2003                             /s/Raul S. McQuivey
Date        	                       ____________________________
						     Raul S. McQuviey
                                         Principal Executive Officer

March 31, 2003                             /s/Sidney C. Hooper
Date                                     ____________________________
						     Sidney C. Hooper
                                         Principal Accounting Officer
#### § 65a.10 For what purposes may grant funds be spent?

A grantee shall spend funds it receives under this part solely in accordance with the approved application and budget, the regulations of this part, the terms and conditions of the award, and the applicable cost principles prescribed in 45 CFR part 75, subpart E.

[61 FR 55114, Oct. 24, 1996, as amended at 81 FR 3010, Jan. 20, 2016]
#### § 17.83 Limitations on payment for alcohol and drug dependence or abuse treatment and rehabilitation.

The authority to enter into contracts shall be effective for any fiscal year only to such extent or in such amounts as are provided in appropriation acts, and payments shall not exceed these amounts.

(Authority: Pub. L. 96-22, 38 U.S.C. 1720A)

[47 FR 57708, Dec. 28, 1982. Redesignated at 61 FR 21965, May 13, 1996]
#### § 52a.9 Additional conditions.

The Director may, with respect to any grant award, impose additional conditions prior to or at the time of any award when in the Director's judgment the conditions are necessary to assure the carrying out of the purposes of the award, the interests of the public health, or the conservation of grant funds.

[61 FR 55110, Oct. 24, 1996]
Filed 2/16/22 P. v. Cole CA4/1

NOT TO BE PUBLISHED IN OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for 

publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication

or ordered published for purposes of rule 8.1115. 

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

THE PEOPLE,

Plaintiff and Respondent,

v.

RALPH COLE,

Defendant and Appellant.

 D079263

 (Super. Ct. No. JCF27233)

APPEAL from a judgment of the Superior Court of Imperial County, 

William D. Lehman, Judge. Affirmed. 

John L. Staley, under appointment by the Court of Appeal, for 

Defendant and Appellant.

No appearance for Plaintiff and Respondent. 

In 2011, Ralph Cole pleaded no contest to possession of marijuana in a 

custodial facility (Pen. Code, § 4573.6). He was sentenced to three years in 

prison, to be served consecutively to his existing prison terms. 
2

In 2021, Cole filed a motion to vacate his conviction in light of 

Proposition 64, which changed the laws regarding possession of marijuana. 

The trial court denied the motion.1 

Cole filed a timely notice of appeal. 

Appellate counsel has filed a brief pursuant to People v. Wende (1979) 

25 Cal.3d 436 (Wende), indicating counsel has not been able to identify any 

arguable issues for reversal on appeal. Counsel asks the court to review the 

record for error as mandated by Wende. We offered Cole the opportunity to 

file his own brief on appeal, but he has not responded.

STATEMENT OF FACTS

The probation report states that Cole possessed 8.7 grams and 44.3 

grams of marijuana while in a state prison. 

DISCUSSION

As we have noted, appellate counsel has filed a Wende brief and asks 

the court to review the record for error. To assist the court in its review, and 

in compliance with Anders v. California (1967) 386 U.S. 738 (Anders), counsel 

has identified a possible issue that was considered in evaluating the potential 

merits of this appeal: Whether the trial court erred in denying Cole’s motion 

to vacate his conviction for possessing marijuana in state prison.

We have reviewed the entire record as mandated by Wende and Anders. 

We have not discovered any arguable issues for reversal on appeal. 

Competent counsel has represented Cole on this appeal.

1 People v. Raybon (2021) 11 Cal. 5th 1056 held Proposition 64 did not 

repeal Penal Code section 4573.6.
3

DISPOSITION

The judgment is affirmed.

HUFFMAN, Acting P. J.

WE CONCUR:

O'ROURKE, J.

DO, J.
#### § 86.4 Publications and copyrights.

Except as may otherwise be provided under the terms and conditions of the award, the grantee may copyright without prior approval any publications, films or similar materials developed or resulting from a project supported by a grant under this part, subject, however, to a royalty-free, nonexclusive, and irrevocable license or right in the Government to reproduce, translate, publish, use, disseminate, and dispose, of such materials and to authorize others to do so.
----

            COMMISSION DECISION         

of 31 March 2005         

concerning the non-inclusion of cresylic acid, dichlorophen, imazamethabenz, kasugamycin and polyoxin in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing these substances

(notified under document number C(2005) 975)

(Text with EEA relevance)

(2005/303/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (1), and in particular the fourth subparagraph of Article 8(2) thereof,

Whereas:

HAS ADOPTED THIS DECISION:

Article 1

Cresylic acid, dichlorophen, imazamethabenz, kasugamycin and polyoxin shall not be included in Annex I to Directive 91/414/EEC.

Article 2

Member States shall ensure that:

Article 3

Any period of grace granted by Member States in accordance with Article 4(6) of Directive 91/414/EEC, shall be as short as possible.

Where authorisations shall be withdrawn in accordance with Article 2(1) by 30 September 2005 at the latest, the period shall expire on 30 September 2006 at the latest.

Where authorisations shall be withdrawn in accordance with Article 2(3) by 30 June 2007 at the latest, the period shall expire on 31 December 2007 at the latest.

Article 4

This Decision is addressed to the Member States.

Done at Brussels, 31 March 2005.

For the Commission

Markos KYPRIANOU            

Member of the Commission

----

(1)OJ L 230, 19.8.1991, p. 1. Directive as last amended by Commission Directive 2004/58/EC (OJ L 120, 24.4.2004, p. 26).

(2)OJ L 55, 29.2.2000, p. 25. Regulation as last amended by Regulation (EC) No 1044/2003 (OJ L 151, 19.6.2003, p. 32).

(3)OJ L 224, 21.8.2002, p. 23. Regulation as last amended by Regulation (EC) No 1744/2004 (OJ L 311, 8.10.2004, p. 23).

----

ANNEX

LIST OF AUTHORISATIONS REFERRED TO IN ARTICLE 2(2)

----
§ 17.502 Applicability of other statutes. ( a ) Disclosure of quality assurance records and documents which are not confidential and privileged under 38 U.S.C. 5705 and the confidentiality regulations in §§ 17.500 through 17.511 will be governed by the provisions of the Freedom of Information Act, and, if applicable, the Privacy Act and any other VA or federal confidentiality statutes.
( b ) When included in a quality assurance review, confidential records protected by other confidentiality statutes such as 5 U.S.C. 552a (the Privacy Act), 38 U.S.C. 7332 (drug and alcohol abuse, sickle cell anemia, HIV infection), and 38 U.S.C. 5701 (veterans' names and addresses) retain whatever confidentiality protection they have under these laws and applicable regulations and will be handled accordingly. To the extent that information protected by 38 U.S.C. 5701 or 7332 or the Privacy Act is incorporated into quality assurance records, the information in the quality assurance records is still protected by these statutes.
(Authority: 38 U.S.C. 5705)
<PAGE>

I, William R. Sprow, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Sentex Sensing
Technology, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:  July 7, 2004

/s/ William R. Sprow, Chief Financial Officer
-----------------------------------------------
Signature & Title


                                       13
Amendment Number 4 to the Group Purchasing Agreement



 Exhibit 10.34 
 PREMIER PURCHASING PARTNERS, L.P. 
 AMENDMENT NUMBER 4 TO GROUP PURCHASING AGREEMENT 

CONTRACT #:     PP-NS-347     
 Product Category:         Pulse Oximeters         
 Amendment of Section 8.11 HL7 Compliance 
 This Amendment Number 4 (“Amendment”), is entered into effective December 1, 2007 (the “Effective Date”), and shall amend and modify the Group Purchasing Agreement (Contract #: PP-NS-347) by and between Premier
Purchasing Partners, L.P. (“Purchasing Partners”), and Masimo Americas, Inc. (“Seller”), dated effective March 1, 2006 (the “Agreement”), as follows: 
 1. Amendment of Section 8.11 HL7 Compliance. Effective as of the Effective Date, Section 8.11 HL7 Compliance to the Agreement is hereby
amended and restated to and will read as follows: 
  

	 	8.11	HL7 Compliance. Vendor enables HL7 connectivity through and option of the RadNet central station product. This option contains the necessary hardware and software
required to translate patient data into HL7 compliant protocols. Connectivity to the customer’s HL7 compliant Electronic Medical Record will require some level of customization of the protocol dependent of the customer’s EMR vendor, HL7
version and end user requirements. Such customization is available at an additional fee depending on the requirements and scope of the interface. 

 2. Other Terms and Conditions. All other terms and conditions of the Agreement shall remain in full force and effect. 
 This Amendment is hereby executed as of the Effective Date by the parties’ authorized representatives set forth below. 
  

							
	 PREMIER PURCHASING PARTNERS, L.P.
 (“Purchasing Partners”)
	 	 Masimo Americas, Inc.

		 	(“Seller”)
				
	By:	 	PREMIER PLANS, L.L.C.,	 		 	
		 	Its General Partner	 		 	
				
	By:	 	 /s/ John J. Biggers, Jr.
	 	By:	 	 /s/ Jim Beyer

				
	Printed Name:	 	 John J. Biggers, Jr.
	 	Printed Name:	 	 Jim Beyer

				
	Title:	 	 Group Vice President, Sourcing
	 	Title:	 	 Vice President, National Accounts

				
	By:	 	 /s/ John W. Hargette
	 		 	
				
	Printed Name:	 	 John W. Hargette
	 		 	
				
	Title:	 	 Vice President, Sourcing
<PAGE>

                                                                    Exhibit 23.3
                             HUNTLEY & HUNTLEY, INC.
                            GEOLOGISTS AND ENGINEERS

                                                     CORPORATE ONE II, SUITE 100
L.G. HUNTLEY 1912-1970       ESTABLISHED 1912         4075 MONROEVILLE BOULEVARD
J.R. WYLIE, JR. 1927-1974                                  MONROEVILLE, PA 15146
R.S. STEWART 1948-1988                                            ----
T. BARTHOLOMEW, II                                            AREA CODE 412
              1988-1994                                         380-2355
                                                               Fax Number
                                                                380-4003



                                November 17, 1997



Mr. Richard E. Staedtler
Chief Financial Officer
Castle Energy Corporation
One Radnor Corporate Center, Suite 250
Radnor, PA   19087

Dear Mr. Staedtler:

         We hereby consent to the use of our name and reference to our report
dated October 23, 1997 in the Form 10-K of Castle Energy Corporation for the
year ended September 30, 1997.

Sincerely,



/s/ Keith N. Mangini
------------------------------
By:  Keith N. Mangini
President
November 17, 1997
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Quarterly  Report  of  First  Financial  Bancorp  (the
"Company") on Form 10-Q for the period  ending  September 30, 2003 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Allen R. Christenson,  Chief Financial Officer of the Company, certify, pursuant
to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to  Section  906  of  the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information  contained in the Report fairly  presents,  in
                  all material respects,  the financial condition and results of
                  operations of the Company.


November 12, 2003                                    /s/Allen R. Christenson
                                                     ---------------------------
                                                     Chief Financial Officer
#### § 17.54 [Reserved]
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### §§ 1.317-1.318 [Reserved]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
----

            COMMISSION DECISION         

of 7 May 2004         

on the aid scheme which Italy is planning to implement to assist farmers in the province of Campobasso

(notified under document number C(2004) 1634)

(Only the Italian text is authentic)

(2005/319/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community, and in particular the first subparagraph of Article 88(2) thereof,

Having called on interested parties to submit their comments pursuant to the provision cited above,

Whereas:

I.   PROCEDURE

II.   DESCRIPTION OF THE AID

1.   The aid scheme

2.   Grounds on which proceedings were initiated by the Commission

A.   Doubts regarding the types of investment eligible for aid

B.   Doubts regarding the nature and rate of financing of certain types of eligible expenditure

C.   Doubts regarding the reliability of the criteria used for assessing the viability of the recipients and the latter’s compliance with minimum environmental, hygiene and animal welfare standards.

D.   Doubts regarding the possible retrospective nature of the aid

III.   COMMENTS SUBMITTED BY ITALY AND OTHER PARTIES

IV.   LEGAL ASSESSMENT

1.   Existence of aid within the meaning of Article 87(1) of the Treaty

2.   Scrutiny of the compatibility of the aid

V.   CONCLUSIONS

HAS ADOPTED THIS DECISION:

Article 1

The aid which Italy is planning to grant, on the basis of Decision No 629 of 29 December 1999 of the Campobasso Provincial Executive, to finance agricultural activities aimed at improving the quality of products and the quality of life of operators is incompatible with the common market.

The aid scheme may accordingly not be implementsed.

Article 2

Italy shall inform the Commission, within two months of notification of this Decision, of the measures taken to comply with it.

Article 3

This Decision is addressed to the Italian Republic.

Done at Brussels, 7 May 2004.

For the Commission

Franz FISCHLER            

Member of the Commission

----

(1)OJ C 354, 13.12.2001, p. 18.

(2)OJ L 160, 26.6.1999, p. 80. Regulation as last amended by Regulation (EC) No 2223/2004 (OJ L 379, 24.12.2004, p. 1).

(3)OJ C 28, 1.2.2000, p. 2. Corrigendum published in OJ C 232, 12.8.2000, p. 17.

(4)OJ L 214, 13.8.1999, p. 31. Regulation as last amended by Regulation (EC) No 1763/2001 (OJ L 239, 7.9.2001, p. 10).

(5)OJ L 1, 3.1.2004, p. 1.

(6)  Cf. first subparagraph of Article 20(2) of the Regulation.

----